CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director

CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing

CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors SAN MATEO, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...

CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update CARGO Therapeutics today provided a business update and reported financial results for the quarter and year ending December 31, 2023.